US Broker Ratings

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Powerhouse with 53.90% Potential Upside

Corcept Therapeutics Incorporated (CORT), a prominent player in the biotechnology sector, has been making waves in the healthcare industry with its innovative approach to tackling severe endocrinologic, oncologic, metabolic, and..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Promising 18.55% Potential Upside for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands out within the healthcare sector as a compelling investment opportunity, particularly for those focused on the dynamic medical instruments and supplies industry. With..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring Growth Potential and Market Position

Henry Schein, Inc. (HSIC) stands as a significant player in the healthcare sector, specifically within the medical distribution industry. With a robust market capitalization of $9.23 billion, the company has..

Stevanato Group S.p.A. (STVN): Analyst Consensus Projects a 38% Upside for This Italian Healthcare Giant

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, has caught the attention of investors with its robust position in the medical instruments and supplies industry. Headquartered..

Tempus AI, Inc. (TEM) Stock Analysis: 41.81% Potential Upside Amid Robust Revenue Growth

Investors are keeping a close eye on Tempus AI, Inc. (NASDAQ: TEM), a healthcare technology company specializing in molecular and anatomical diagnostics, as it presents an intriguing investment opportunity with..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 7.53% Potential Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, is garnering attention from investors seeking stability and growth within the medical instruments and supplies industry. With a market..

Fresenius Medical Care AG (FMS) Stock Analysis: A 19.55% Potential Upside Beckons Investors

Fresenius Medical Care AG (NYSE: FMS), a dominant player in the healthcare sector, specializes in providing essential dialysis and related services to patients with renal diseases globally. With a market..

Glaukos Corporation (GKOS) Stock Analysis: Exploring Strong Buy Ratings Amid a 38.10% Revenue Growth

Glaukos Corporation (NYSE: GKOS), a leader in ophthalmic pharmaceutical and medical technology, presents a compelling opportunity for investors with its innovative products and significant revenue growth. Operating in the healthcare..

GSK plc (GSK) Investor Outlook: Navigating a Strong Healthcare Portfolio with a 3.44% Dividend Yield

GSK plc (NYSE: GSK), a titan in the healthcare sector, is captivating investors with its comprehensive portfolio of vaccines, specialty, and general medicines. Headquartered in London, this UK-based company is..

ResMed Inc. (RMD): Analyst Ratings and Revenue Growth Signal Strong Investment Potential

ResMed Inc. (NYSE: RMD), a formidable player in the healthcare sector, specializes in medical instruments and supplies, specifically focusing on respiratory disorders. With a robust market capitalization of $35.73 billion,..

Ascendis Pharma A/S (ASND) Stock Analysis: 25% Upside Potential and Strong Buy Ratings Fuel Investor Interest

Investors with a keen eye on the biotech sector will find Ascendis Pharma A/S (NASDAQ: ASND) an intriguing opportunity. Based in Hellerup, Denmark, this innovative biopharmaceutical company is making waves..

Elevance Health, Inc. (ELV): Investor Outlook on a Healthcare Giant with 11.24% Upside Potential

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, presents an interesting opportunity for investors seeking exposure in the healthcare sector. With a robust market capitalization..

ICON plc (ICLR) Stock Analysis: Navigating the Healthcare Sector with a 12.87% Upside Potential

ICON plc (ICLR), a prominent player in the healthcare sector, offers investors an intriguing opportunity, especially with a projected upside potential of 12.87%. Based in Dublin, Ireland, ICON specializes in..

Humana Inc. (HUM) Stock Analysis: Navigating Upside and Analyst Ratings in Healthcare Plans

Investors with an eye on healthcare plans should give Humana Inc. (NYSE: HUM) a closer look. With a market capitalization of $31.13 billion, Humana stands as a significant player in..

Alcon Inc. (ALC) Stock Analysis: A 14.57% Upside Potential in the Healthcare Sector

Alcon Inc. (NYSE: ALC), a leading player in the healthcare sector specializing in medical instruments and supplies, presents a compelling opportunity for investors seeking exposure to the dynamic field of..

DexCom, Inc. (DXCM) Stock Analysis: Exploring a 26.19% Upside in the Medical Devices Sector

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector with a strong focus on medical devices, is making waves with its continuous glucose monitoring (CGM) systems. With a market..

Molina Healthcare Inc (MOH) Stock Analysis: Growth Potential and Analyst Insights

Molina Healthcare Inc (MOH), a prominent player in the healthcare sector, stands out due to its focus on providing managed healthcare services to low-income families and individuals through Medicaid and..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 11.26% Potential Upside for this Healthcare Powerhouse

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable entity in the healthcare sector, specifically within the diagnostics and research industry. With a commanding market cap of $55.08 billion, IDEXX..

Insmed Incorporated (INSM) Stock Analysis: A Biotech Pioneer with 20.84% Potential Upside

Insmed Incorporated (NASDAQ: INSM) is making waves in the biotechnology sector, catching the attention of investors with its advanced pipeline and significant growth potential. With a market capitalization of $37.94..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 55% Potential Upside in the Health Information Services Sector

Doximity, Inc. (NYSE: DOCS) is carving its niche within the healthcare sector as a vital digital platform for medical professionals. With a current market capitalization of $8.23 billion, Doximity stands..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds